smoking weed on glp 1 IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target Could GLP‑1s Curb Addiction to

2011 Lancet) The combination is more effective than either drug alone at lower doses, and the lower doses reduce side effects of both components

The Precision Peptide Genetic Test ($99 add-on or $298 standalone) identifies genetic predispositions relevant to GLP-1 efficacy and tolerability, but it does not predict exact medication response or guarantee outcomes

Understanding this mechanism is essential

After some research, I found a second more helpful page

In this context, the antitumor activity reported for incretin-based polyagonists should not be interpreted as evidence for GCGR agonism alone, but rather as an indication that coordinated multi-receptor targeting may induce favorable systemic metabolic remodeling (62,63)

However, it remains uncertain whether analogous mechanisms operate for fructose